{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:47:35Z","timestamp":1794037655093,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100131"],"award-info":[{"award-number":["82100131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573860"],"award-info":[{"award-number":["81573860"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-MSX0136"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0136"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86622-7","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T14:29:27Z","timestamp":1738679367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Yiqi Juanshen decoction alleviates renal interstitial fibrosis by targeting the LOXL2\/PI3K\/AKT pathway to suppress EMT and inflammation"],"prefix":"10.1038","volume":"15","author":[{"given":"Kaiyue","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"86622_CR1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen, T. K., Knicely, D. H. & Grams, M. E. Chronic kidney disease diagnosis and management: a review. JAMA 322, 1294\u20131304. https:\/\/doi.org\/10.1001\/jama.2019.14745 (2019).","journal-title":"JAMA"},{"key":"86622_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"Collaboration, G. B. D. C. K. D.","year":"2020","unstructured":"Collaboration, G. B. D. C. K. D. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of Disease Study 2017. Lancet 395, 709\u2013733. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3 (2020).","journal-title":"Lancet"},{"key":"86622_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L. & Perkovic, V. Chronic kidney disease. Lancet 398, 786\u2013802. https:\/\/doi.org\/10.1016\/S0140-6736(21)00519-5 (2021).","journal-title":"Lancet"},{"key":"86622_CR4","doi-asserted-by":"publisher","unstructured":"Panizo, S. et al. Fibrosis in chronic kidney disease: Pathogenesis and consequences. Int. J. Mol. Sci. 22. https:\/\/doi.org\/10.3390\/ijms22010408 (2021).","DOI":"10.3390\/ijms22010408"},{"key":"86622_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","volume":"7","author":"Y Liu","year":"2011","unstructured":"Liu, Y. Cellular and molecular mechanisms of renal fibrosis. Nat. Rev. Nephrol. 7, 684\u2013696. https:\/\/doi.org\/10.1038\/nrneph.2011.149 (2011).","journal-title":"Nat. Rev. Nephrol."},{"key":"86622_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.gendis.2020.06.001","volume":"9","author":"H Yuan","year":"2022","unstructured":"Yuan, H., Wu, X., Wang, X. & Yuan, C. Chinese herbal decoction astragalus and angelica exerts its therapeutic effect on renal interstitial fibrosis through the inhibition of MAPK, PI3K-Akt and TNF signaling pathways. Genes Dis. 9, 510\u2013521. https:\/\/doi.org\/10.1016\/j.gendis.2020.06.001 (2022).","journal-title":"Genes Dis."},{"key":"86622_CR7","doi-asserted-by":"publisher","first-page":"154873","DOI":"10.1016\/j.phymed.2023.154873","volume":"116","author":"R Li","year":"2023","unstructured":"Li, R. et al. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K\/AKT. Phytomedicine 116, 154873. https:\/\/doi.org\/10.1016\/j.phymed.2023.154873 (2023).","journal-title":"Phytomedicine"},{"key":"86622_CR8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fphar.2020.00604","volume":"11","author":"L Zheng","year":"2020","unstructured":"Zheng, L. et al. Distinct responses of gut microbiota to Jian-Pi-Yi-Shen decoction are associated with improved clinical outcomes in 5\/6 nephrectomized rats. Front. Pharmacol. 11, 604. https:\/\/doi.org\/10.3389\/fphar.2020.00604 (2020).","journal-title":"Front. Pharmacol."},{"key":"86622_CR9","doi-asserted-by":"publisher","first-page":"900491","DOI":"10.3389\/fphar.2022.900491","volume":"13","author":"XY Liu","year":"2022","unstructured":"Liu, X. Y., Zhang, X. B., Zhao, Y. F., Qu, K. & Yu, X. Y. Research progress of Chinese herbal medicine intervention in renal interstitial fibrosis. Front. Pharmacol. 13, 900491. https:\/\/doi.org\/10.3389\/fphar.2022.900491 (2022).","journal-title":"Front. Pharmacol."},{"key":"86622_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.freeradbiomed.2021.05.034","volume":"172","author":"AK Aranda-Rivera","year":"2021","unstructured":"Aranda-Rivera, A. K., Cruz-Gregorio, A., Aparicio-Trejo, O. E., Ortega-Lozano, A. J. & Pedraza-Chaverri, J. Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis. Free Radic. Biol. Med. 172, 65\u201381. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.05.034 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"86622_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41401-019-0324-7","volume":"41","author":"XQ Geng","year":"2020","unstructured":"Geng, X. Q. et al. Ganoderic acid hinders renal fibrosis via suppressing the TGF-beta\/Smad and MAPK signaling pathways. Acta Pharmacol. Sin. 41, 670\u2013677. https:\/\/doi.org\/10.1038\/s41401-019-0324-7 (2020).","journal-title":"Acta Pharmacol. Sin"},{"key":"86622_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.2009.86","volume":"75","author":"RL Chevalier","year":"2009","unstructured":"Chevalier, R. L., Forbes, M. S. & Thornhill, B. A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 75, 1145\u20131152. https:\/\/doi.org\/10.1038\/ki.2009.86 (2009).","journal-title":"Kidney Int."},{"key":"86622_CR13","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1093\/ndt\/gfi045","volume":"20","author":"H Sugiyama","year":"2005","unstructured":"Sugiyama, H. et al. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol. Dial. Transpl. 20, 2670\u20132680. https:\/\/doi.org\/10.1093\/ndt\/gfi045 (2005).","journal-title":"Nephrol. Dial. Transpl."},{"key":"86622_CR14","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353\u2013D361. https:\/\/doi.org\/10.1093\/nar\/gkw1092 (2017).","journal-title":"Nucleic Acids Res."},{"key":"86622_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.7150\/ijbs.39024","volume":"16","author":"Y Bai","year":"2020","unstructured":"Bai, Y. et al. Ruxolitinib alleviates renal interstitial fibrosis in UUO mice. Int. J. Biol. Sci. 16, 194\u2013203. https:\/\/doi.org\/10.7150\/ijbs.39024 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"86622_CR16","doi-asserted-by":"publisher","unstructured":"Li, R. et al. Salidroside ameliorates renal interstitial fibrosis by inhibiting the TLR4\/NF-kappaB and MAPK signaling pathways. Int. J. Mol. Sci. 20. https:\/\/doi.org\/10.3390\/ijms20051103 (2019).","DOI":"10.3390\/ijms20051103"},{"key":"86622_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nm.3901","volume":"21","author":"MT Grande","year":"2015","unstructured":"Grande, M. T. et al. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat. Med. 21, 989\u2013997. https:\/\/doi.org\/10.1038\/nm.3901 (2015).","journal-title":"Nat. Med."},{"key":"86622_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00441-016-2464-0","volume":"365","author":"RC Stone","year":"2016","unstructured":"Stone, R. C. et al. Epithelial-mesenchymal transition in tissue repair and fibrosis. Cell. Tissue Res. 365, 495\u2013506. https:\/\/doi.org\/10.1007\/s00441-016-2464-0 (2016).","journal-title":"Cell. Tissue Res."},{"key":"86622_CR19","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1096\/fj.09-151639","volume":"24","author":"MG Mendez","year":"2010","unstructured":"Mendez, M. G., Kojima, S. & Goldman, R. D. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 24, 1838\u20131851. https:\/\/doi.org\/10.1096\/fj.09-151639 (2010).","journal-title":"FASEB J."},{"key":"86622_CR20","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3892\/mmr.2014.2323","volume":"10","author":"GT Jiang","year":"2014","unstructured":"Jiang, G. T., Chen, X., Li, D., An, H. X. & Jiao, J. D. Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction. Mol. Med. Rep. 10, 1501\u20131508. https:\/\/doi.org\/10.3892\/mmr.2014.2323 (2014).","journal-title":"Mol. Med. Rep."},{"key":"86622_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/01.asn.0000111246.87175.32","volume":"15","author":"V Eis","year":"2004","unstructured":"Eis, V. et al. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J. Am. Soc. Nephrol. 15, 337\u2013347. https:\/\/doi.org\/10.1097\/01.asn.0000111246.87175.32 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"86622_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","volume":"9","author":"W Xu","year":"2015","unstructured":"Xu, W., Yang, Z. & Lu, N. A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition. Cell. Adhes. Migr. 9, 317\u2013324. https:\/\/doi.org\/10.1080\/19336918.2015.1016686 (2015).","journal-title":"Cell. Adhes. Migr."},{"key":"86622_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-024-03989-8","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. The role of PI3K\/Akt signaling pathway in chronic kidney disease. Int. Urol. Nephrol. https:\/\/doi.org\/10.1007\/s11255-024-03989-8 (2024).","journal-title":"Int. Urol. Nephrol."},{"key":"86622_CR24","doi-asserted-by":"publisher","first-page":"10568","DOI":"10.1038\/srep10568","volume":"5","author":"X Grau-Bove","year":"2015","unstructured":"Grau-Bove, X., Ruiz-Trillo, I. & Rodriguez-Pascual, F. Origin and evolution of lysyl oxidases. Sci. Rep. 5, 10568. https:\/\/doi.org\/10.1038\/srep10568 (2015).","journal-title":"Sci. Rep."},{"key":"86622_CR25","doi-asserted-by":"publisher","unstructured":"Erasmus, M. et al. Linking LOXL2 to cardiac interstitial fibrosis. Int. J. Mol. Sci. 21. https:\/\/doi.org\/10.3390\/ijms21165913 (2020).","DOI":"10.3390\/ijms21165913"},{"key":"86622_CR26","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster, A. C., Nagler, E. V., Morton, R. L. & Masson, P. Chronic kidney disease. Lancet 389, 1238\u20131252. https:\/\/doi.org\/10.1016\/S0140-6736(16)32064-5 (2017).","journal-title":"Lancet"},{"key":"86622_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12272-022-01375-5","volume":"45","author":"S Ha","year":"2022","unstructured":"Ha, S., Chung, K. W., Lee, J., Chung, H. Y. & Moon, H. R. Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process. Arch. Pharm. Res. 45, 159\u2013173. https:\/\/doi.org\/10.1007\/s12272-022-01375-5 (2022).","journal-title":"Arch. Pharm. Res."},{"key":"86622_CR28","doi-asserted-by":"publisher","unstructured":"Dong, X., Wang, Y., Zhuang, H. & An, G. Hydroxygenkwanin suppresses proliferation, invasion and migration of osteosarcoma cells via the miR\u2013320a\/SOX9 axis. Mol. Med. Rep. 26. https:\/\/doi.org\/10.3892\/mmr.2022.12815 (2022).","DOI":"10.3892\/mmr.2022.12815"},{"key":"86622_CR29","doi-asserted-by":"publisher","first-page":"e34353","DOI":"10.1097\/MD.0000000000034353","volume":"102","author":"Q Han","year":"2023","unstructured":"Han, Q., Zhu, J. & Zhang, P. Mechanisms of main components in Curcuma longa L. on hepatic fibrosis based on network pharmacology and molecular docking: a review. Med. (Baltim). 102, e34353. https:\/\/doi.org\/10.1097\/MD.0000000000034353 (2023).","journal-title":"Med. (Baltim)."},{"key":"86622_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jep.2015.04.037","volume":"169","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. You-gui pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-beta\/Smad signaling pathway. J. Ethnopharmacol. 169, 229\u2013238. https:\/\/doi.org\/10.1016\/j.jep.2015.04.037 (2015).","journal-title":"J. Ethnopharmacol."},{"key":"86622_CR31","doi-asserted-by":"publisher","first-page":"153585","DOI":"10.1016\/j.phymed.2021.153585","volume":"87","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt\/beta-catenin pathway. Phytomedicine 87, 153585. https:\/\/doi.org\/10.1016\/j.phymed.2021.153585 (2021).","journal-title":"Phytomedicine"},{"key":"86622_CR32","doi-asserted-by":"publisher","first-page":"F414","DOI":"10.1152\/ajprenal.00393.2016","volume":"313","author":"S Malik","year":"2017","unstructured":"Malik, S. et al. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-kappaB-TNF-alpha and TGF-beta1-MAPK-fibronectin pathways. Am. J. Physiol. Ren. Physiol. 313, F414\u2013F422. https:\/\/doi.org\/10.1152\/ajprenal.00393.2016 (2017).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"86622_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biocel.2007.01.006","volume":"40","author":"W Qi","year":"2008","unstructured":"Qi, W., Chen, X., Poronnik, P. & Pollock, C. A. Transforming growth factor-beta\/connective tissue growth factor axis in the kidney. Int. J. Biochem. Cell. Biol. 40, 9\u201313. https:\/\/doi.org\/10.1016\/j.biocel.2007.01.006 (2008).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"86622_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-beta: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325\u2013338. https:\/\/doi.org\/10.1038\/nrneph.2016.48 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"86622_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000013603","volume":"20","author":"K Furuichi","year":"2000","unstructured":"Furuichi, K. et al. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am. J. Nephrol. 20, 291\u2013299. https:\/\/doi.org\/10.1159\/000013603 (2000).","journal-title":"Am. J. Nephrol."},{"key":"86622_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1681\/ASN.V111152","volume":"11","author":"S Segerer","year":"2000","unstructured":"Segerer, S., Nelson, P. J. & Schlondorff, D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J. Am. Soc. Nephrol. 11, 152\u2013176. https:\/\/doi.org\/10.1681\/ASN.V111152 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"86622_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1046\/j.1523-1755.2003.00750.x","volume":"63","author":"HJ Anders","year":"2003","unstructured":"Anders, H. J., Vielhauer, V. & Schlondorff, D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int. 63, 401\u2013415. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00750.x (2003).","journal-title":"Kidney Int."},{"key":"86622_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1098-1136(200003)30:1<1::AID-GLIA1>3.0.CO;2-Q","volume":"30","author":"Y Han","year":"2000","unstructured":"Han, Y., Wang, J., Zhou, Z. & Ransohoff, R. M. TGFbeta1 selectively up-regulates CCR1 expression in primary murine astrocytes. Glia 30, 1\u201310 (2000).","journal-title":"Glia"},{"key":"86622_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1172\/JCI14040","volume":"109","author":"HJ Anders","year":"2002","unstructured":"Anders, H. J. et al. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J. Clin. Invest. 109, 251\u2013259. https:\/\/doi.org\/10.1172\/JCI14040 (2002).","journal-title":"J. Clin. Invest."},{"key":"86622_CR40","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu, V. S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19, 1047\u20131053. https:\/\/doi.org\/10.1038\/nm.3218 (2013).","journal-title":"Nat. Med."},{"key":"86622_CR41","doi-asserted-by":"publisher","first-page":"14272","DOI":"10.1038\/s41598-017-14612-5","volume":"7","author":"HS Hsu","year":"2017","unstructured":"Hsu, H. S. et al. Involvement of ER stress, PI3K\/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis. Sci. Rep. 7, 14272. https:\/\/doi.org\/10.1038\/s41598-017-14612-5 (2017).","journal-title":"Sci. Rep."},{"key":"86622_CR42","doi-asserted-by":"publisher","first-page":"10169","DOI":"10.26355\/eurrev_201911_19587","volume":"23","author":"YM Du","year":"2019","unstructured":"Du, Y. M. et al. Effect of bradykinin on rats with thromboangiitis obliterans through PI3K\/Akt signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 23, 10169\u201310176. https:\/\/doi.org\/10.26355\/eurrev_201911_19587 (2019).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"86622_CR43","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41419-018-1204-7","volume":"9","author":"JF Zhu","year":"2018","unstructured":"Zhu, J. F. et al. Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K\/AKT signaling activation. Cell. Death Dis. 9, 1154. https:\/\/doi.org\/10.1038\/s41419-018-1204-7 (2018).","journal-title":"Cell. Death Dis."},{"key":"86622_CR44","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2147\/DDDT.S310882","volume":"15","author":"L Lei","year":"2021","unstructured":"Lei, L. et al. Wogonin alleviates kidney tubular epithelial injury in diabetic nephropathy by inhibiting PI3K\/Akt\/NF-kappaB signaling pathways. Drug Des. Devel Ther. 15, 3131\u20133150. https:\/\/doi.org\/10.2147\/DDDT.S310882 (2021).","journal-title":"Drug Des. Dev. Ther."},{"key":"86622_CR45","doi-asserted-by":"publisher","first-page":"6940","DOI":"10.1002\/jcp.27437","volume":"234","author":"ZC Hu","year":"2019","unstructured":"Hu, Z. C. et al. Inhibition of PI3K\/Akt\/NF-kappaB signaling with leonurine for ameliorating the progression of osteoarthritis: in vitro and in vivo studies. J. Cell. Physiol. 234, 6940\u20136950. https:\/\/doi.org\/10.1002\/jcp.27437 (2019).","journal-title":"J. Cell. Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86622-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86622-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86622-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T14:29:30Z","timestamp":1738679370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86622-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86622"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86622-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4248"}}